GW685698X
Showing 1 - 25 of 1,415
Discontinuation in Adults on Metabolic Profile, Body Composition
Recruiting
- Adult Growth Hormone Deficiency
- Dual energy X-ray absorptiometry (DXA)
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
Jul 28, 2023
Rhinitis, Allergic, Seasonal Trial (GW685698X Aqueous Nasal Spray)
Completed
- Rhinitis, Allergic, Seasonal
- GW685698X Aqueous Nasal Spray
-
,GSK Investigational Site
Aug 30, 2018
Pulmonary Disease, Chronic Obstructive Trial in United States (Batefenterol + Fluticasone Furoate, Placebo, Albuterol)
Completed
- Pulmonary Disease, Chronic Obstructive
- Batefenterol + Fluticasone Furoate
- +2 more
-
Phoenix, Arizona
- +9 more
Jul 13, 2020
Asthma Trial (GW685698X)
Completed
- Asthma
- GW685698X
- (no location specified)
Oct 31, 2017
Burns Trial in Worldwide (Enteral Glutamine, Placebo)
Active, not recruiting
- Burns
- Enteral Glutamine
- Placebo
-
Mobile, Alabama
- +52 more
Dec 9, 2021
Asthma Trial in Wellington (GW685698X, GW685698X containing magnesium stearate)
Completed
- Asthma
- GW685698X
- GW685698X containing magnesium stearate
-
Wellington, New ZealandGSK Investigational Site
Aug 3, 2017
Asthma Trial in Melbourne (GW685698X, Placebo)
Completed
- Asthma
- GW685698X
- Placebo
-
Melbourne, Victoria, AustraliaGSK Investigational Site
Aug 2, 2017
Asthma Trial in Worldwide (GW685698X 200mcg,GW685698X 200mcg and 400mcg)
Completed
- Asthma
- GW685698X 200mcg,GW685698X 200mcg and 400mcg
-
Fullerton, California
- +81 more
Jan 18, 2018
Asthma Trial in Kagoshima (Placebo, GW685698X)
Completed
- Asthma
- Placebo
- GW685698X
-
Kagoshima, JapanGSK Investigational Site
Aug 1, 2017
Asthma Trial in Randwick, Sydney (GW685698X & GW642444M)
Completed
- Asthma
- GW685698X & GW642444M
-
Randwick, Sydney, New South Wales, AustraliaGSK Investigational Site
Aug 2, 2017
Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)
Not yet recruiting
- Allogeneic Disease
- +2 more
- WJ-MSC infusion
- (no location specified)
May 4, 2023
Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)
Completed
- Asthma
- FF/VI via ELLIPTA DPI
- FF via ELLIPTA DPI
-
Hoover, Alabama
- +183 more
Sep 12, 2022
Fistulizing Crohns Disease, Perianal Crohns Disease Trial in Worldwide (Guselkumab, Placebo)
Recruiting
- Fistulizing Crohns Disease
- Perianal Crohns Disease
- Guselkumab
- Placebo
-
Birmingham, Alabama
- +150 more
Aug 11, 2022
Coronary Artery Disease, Myocardial Ischaemia, Coronary Circulation Trial in Beijing (QFR, Angiography)
Active, not recruiting
- Coronary Artery Disease
- +4 more
- QFR
- Angiography
-
Beijing, Beijing, ChinaFu Wai Hospital, National Center for Cardiovascular Diseases, Ch
Dec 16, 2022
Coronary Artery Calcification Trial in Roma (intravascular lithotripsy with Shockwave coronary system)
Recruiting
- Coronary Artery Calcification
- intravascular lithotripsy with Shockwave coronary system
-
Roma, Rome, ItalyUniversity of Rome Tor Vergata - Policlinico
Jul 25, 2023
Asthma Trial in Randwick (Fluticasone foroate/ vilanterol, Fluticasone foroate, Vilanterol)
Completed
- Asthma
- Fluticasone foroate/ vilanterol
- +3 more
-
Randwick, New South Wales, AustraliaGSK Investigational Site
Aug 16, 2017
Identifying Vulnerable CoronAry PLaqUes With Artificial
Enrolling by invitation
- Coronary Artery Disease
- Plaque, Atherosclerotic
- Intravascular imaging test
-
Nanjing, Jiangsu, ChinaResearch Institute Of Medical Imaging Jinling Hospital
Sep 5, 2023
Liver Cirrhosis, Biliary Trial in Worldwide (Obeticholic Acid (OCA), Placebo)
Terminated
- Liver Cirrhosis, Biliary
- Obeticholic Acid (OCA)
- Placebo
-
Los Angeles, California
- +130 more
Jan 14, 2022
Arnuity® Ellipta® Drug Use Investigation
Completed
- Asthma
- Arnuity Ellipta
-
Hokkaido, Japan
- +1 more
Apr 22, 2021
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,
Recruiting
- Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
- +4 more
- tabelecleucel
-
Duarte, California
- +70 more
Jun 23, 2022